CD47

CD47 是一种糖蛋白,于 1990 年首次被鉴定为与整合素相关的蛋白质,因此其原名为整合素相关蛋白。CD47 与 SIRPα (CD172a 或 SHPS-1) 及其家族成员 SIRPγ 相互作用,CD47 还与整合素和分泌性糖蛋白细胞外基质蛋白血小板反应蛋白-1 (TSP-1) 相互作用。通过 CD47/SIRPα 轴的信号传导在各种稳态过程中发挥作用,例如维持红细胞、先天免疫细胞和 T 细胞。此外,癌细胞和病毒感染和细菌感染的细胞可以上调 CD47 蛋白表达,以防止免疫介导的消除。

CD47 is a glycoprotein that was first identified in 1990 as a protein that associates with integrins, hence its original name integrin-associated protein. CD47 interacts with SIRPα (CD172a or SHPS-1) and its family member SIRPγ, CD47 also interacts with integrins and secreted glycoprotein extracellular matrix protein thrombospondin-1 (TSP-1). Signaling through the CD47/SIRPα axis plays a role in various homeostatic processes, such as maintenance of erythrocytes, innate immune cells and T cells. Moreover, cancer cells and virus-infected and bacteria-infected cells can upregulate CD47 protein expression to prevent immune-mediated elimination.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
PKHB1
txCD47

PKHB1 (txCD47) 是一种 CD47 激动剂和 Thrombospondin-1 肽模拟物,可通过线粒体改变、ROS 生成、内质网形态变化及线粒体膜电位耗散激活 CD47,触发不依赖 Caspase、依赖钙的细胞死亡,并诱导 Calreticulin、HSP70、HSP90 暴露以驱动免疫原性细胞死亡,同时促进瘤内 CD8+ T 细胞浸润、抑制乳腺癌形成、降低 HSV-1 水平并减轻单纯疱疹性角膜炎的严重程度,因此可用于乳腺癌、单纯疱疹性角膜炎和 T 细胞急性淋巴细胞白血病的相关研究。

1505523-99-8
Agonist
99.84%
PKHB1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础